These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32964759)

  • 1. Formation of Calcified Nodule as a Cause of Early In-Stent Restenosis in Patients Undergoing Dialysis.
    Nakamura N; Torii S; Tsuchiya H; Nakano A; Oikawa Y; Yajima J; Nakamura S; Nakano M; Masuda N; Ohta H; Yumoto K; Natsumeda M; Ijichi T; Ikari Y; Nakazawa G
    J Am Heart Assoc; 2020 Oct; 9(19):e016595. PubMed ID: 32964759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency and clinical characteristics of in-stent restenosis due to calcified nodule development after coronary stent implantation.
    Isodono K; Fujii K; Fujimoto T; Kasahara T; Ariyoshi M; Irie D; Tsubakimoto Y; Sakatani T; Matsuo A; Inoue K; Fujita H
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):15-23. PubMed ID: 32734495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-Stent Restenosis with "Inflammatory" Neointima Following Everolimus-Eluting Stent Implantation.
    Tsuji Y; Koide M; Katsura K; Fujita H; Ishibashi-Ueda H; Otsuka F
    Int Heart J; 2018 Sep; 59(5):1142-1145. PubMed ID: 30012926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
    J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant in-stent restenosis in the drug eluting stent era.
    Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
    Huang WC; Teng HI; Chen HY; Wu CJ; Tsai CT; Hsueh CH; Chen YY; Hau WK; Lu TM
    Int J Cardiol; 2019 Aug; 289():131-137. PubMed ID: 31079970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T; Sun JL; Zhang J
    Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.
    Abdel-Wahab M; Toelg R; Byrne RA; Geist V; El-Mawardy M; Allali A; Rheude T; Robinson DR; Abdelghani M; Sulimov DS; Kastrati A; Richardt G
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e007415. PubMed ID: 30354632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules.
    Tada T; Miura K; Ikuta A; Ohya M; Shimada T; Osakada K; Takamatsu M; Taguchi Y; Kubo S; Tanaka H; Fuku Y; Kadota K
    EuroIntervention; 2022 Mar; 17(16):1352-1361. PubMed ID: 34483090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of rotational atherectomy for the implantation of drug-eluting stents in the calcified lesions of hemodialysis patients.
    Fujimoto H; Ishiwata S; Yamaguchi T; Ohno M
    J Cardiol; 2010 Mar; 55(2):232-7. PubMed ID: 20206077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes using the sirolimus-eluting stent in calcified versus non-calcified native coronary lesions in patients on- versus not on-chronic hemodialysis (from the j-Cypher registry).
    Nishida K; Kimura T; Kawai K; Miyano I; Nakaoka Y; Yamamoto S; Kaname N; Seki S; Kubokawa S; Fukatani M; Hamashige N; Morimoto T; Mitsudo K;
    Am J Cardiol; 2013 Sep; 112(5):647-55. PubMed ID: 23707041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Sugi K
    J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of coronary calcification on angiographic and 3-year clinical outcomes of everolimus-eluting stents: results of a XIENCE V/PROMUS post-marketing surveillance study.
    Shiode N; Kozuma K; Aoki J; Awata M; Nanasato M; Tanabe K; Yamaguchi J; Kusano H; Nie H; Kimura T;
    Cardiovasc Interv Ther; 2018 Oct; 33(4):313-320. PubMed ID: 28726115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients.
    Kawaguchi R; Tsurugaya H; Hoshizaki H; Toyama T; Oshima S; Taniguchi K
    Cardiovasc Revasc Med; 2008; 9(1):2-8. PubMed ID: 18206630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime management of severely calcified coronary lesions: the treatment algorithm focused on the shape of calcification.
    Sakakura K; Jinnouchi H; Taniguchi Y; Yamamoto K; Fujita H
    Cardiovasc Interv Ther; 2023 Oct; 38(4):375-380. PubMed ID: 37542662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.